{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.602","meta":{"versionId":"12","lastUpdated":"2021-03-06T01:00:21.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"American Society of Clinical Oncology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-03-06"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.602"}],"version":"20210306","name":"Neurokinin1ReceptorAntagonist","title":"Neurokinin 1 Receptor Antagonist","status":"active","experimental":false,"date":"2021-03-06T01:00:21-05:00","publisher":"American Society of Clinical Oncology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts of medication for Neurokinin 1 Receptor Antagonist.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for Neurokinin 1 Receptor Antagonist: rolapitant, aprepitant, fosnetupitant palonosetron, netupitant palonosetron, fosaprepitant),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.145"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146"]}]},"expansion":{"identifier":"urn:uuid:619a77f2-0e12-4356-973a-eb20b1743d3c","timestamp":"2023-12-10T21:43:21-05:00","total":14,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1552343","display":"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1665503","display":"rolapitant 90 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1729308","display":"aprepitant 125 MG Powder for Oral Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1731075","display":"fosaprepitant 115 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1731077","display":"fosaprepitant 150 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1986885","display":"92.5 ML rolapitant 1.8 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1995150","display":"18 ML aprepitant 7.2 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2044429","display":"fosnetupitant 235 MG / palonosetron 0.25 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2374366","display":"20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2631783","display":"4.4 ML aprepitant 7.2 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"403810","display":"aprepitant 80 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"403811","display":"aprepitant 125 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"644088","display":"aprepitant 40 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"754508","display":"{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack"}]}}